Roivant Sciences Ltd (NASDAQ: ROIV) is -3.89% lower on its value in year-to-date trading and has touched a low of $8.73 and a high of $13.06 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The ROIV stock was last observed hovering at around $11.08 in the last trading session, with the day’s gains setting it 0.29%.
Currently trading at $11.37, the stock is 3.48% and 6.41% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 2.87 million and changing 2.62% at the moment leaves the stock 0.97% off its SMA200. ROIV registered 7.06% gain for a year compared to 6-month loss of -5.88%. The firm has a 50-day simple moving average (SMA 50) of $10.6847 and a 200-day simple moving average (SMA200) of $11.260775.
The stock witnessed a 6.86% gain in the last 1 month and extending the period to 3 months gives it a 7.77%, and is 1.11% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 1.64% over the week and 1.94% over the month.
Roivant Sciences Ltd (ROIV) has around 750 employees, a market worth around $7.73B and $76.19M in sales. Profit margin for the company is -225.71%. Distance from 52-week low is 30.24% and -12.91% from its 52-week high. The company has generated returns on investments over the last 12 months (-3.60%).
The EPS is expected to shrink by -386.31% this year.
Roivant Sciences Ltd (ROIV) Top Institutional Holders
410.0 institutions hold shares in Roivant Sciences Ltd (ROIV), with institutional investors hold 120.70% of the company’s shares. The shares outstanding are 695.94M, and float is at 417.33M with Short Float at 11.80%. Institutions hold 83.46% of the Float.
The top institutional shareholder in the company is SB INVESTMENT ADVISERS (UK) LTD with over 71.36 million shares valued at $754.29 million. The investor’s holdings represent 9.6983% of the ROIV Shares outstanding. As of 2024-06-30, the second largest holder is VIKING GLOBAL INVESTORS LP with 69.16 million shares valued at $730.98 million to account for 9.3985 of the shares outstanding. The other top investors are QVT FINANCIAL LP which holds 66.72 million shares representing 9.0674% and valued at over $705.23 million, while FMR LLC holds 6.3265 of the shares totaling 46.55 million with a market value of $492.05 million.
Roivant Sciences Ltd (ROIV) Insider Activity
The most recent transaction is an insider sale by Ramaswamy Vivek, the company’s 10% Owner. SEC filings show that Ramaswamy Vivek sold 547,430 shares of the company’s common stock on Jun 04 ’25 at a price of $11.34 per share for a total of $6.21 million. Following the sale, the insider now owns 38.63 million shares.
Roivant Sciences Ltd disclosed in a document filed with the SEC on Jun 06 ’25 that Ramaswamy Vivek (10% Owner) sold a total of 200,800 shares of the company’s common stock. The trade occurred on Jun 06 ’25 and was made at $11.19 per share for $2.25 million. Following the transaction, the insider now directly holds 38.43 million shares of the ROIV stock.
Still, SEC filings show that on Jun 06 ’25, Ramaswamy Vivek (10% Owner) Proposed Sale 200,800 shares at an average price of $11.19 for $2.25 million. The insider now directly holds shares of Roivant Sciences Ltd (ROIV).
